27 February 2026
Vulcan Two Group plc
(the "Company" or "Vulcan Two")
Posting of Admission Document
Further to the Result of Placing announcement released today at 7.00 a.m., Vulcan Two Group plc, the company aiming to create the UK's leading regulated ePharmacy through buy-and-build, confirms that the Admission Document, containing further details on the Acquisitions and the Placing, will be posted to shareholders today. The Admission Document contains a Notice of General Meeting to be held at the offices of Canaccord Genuity Ltd, 88 Wood Street, London EC2V 7QR on 17 March 2026 at 10.00 a.m. (UK time).
The Board considers that each Acquisition and the Placing are in the best interests of the Company and its Shareholders and, accordingly, unanimously recommends that all Shareholders vote in favour of each of the Resolutions to be proposed at the General Meeting. The Directors intend to vote in favour of the Resolutions in respect of their aggregate beneficial shareholdings, representing approximately 22.3 per cent. of the Existing Ordinary Share Capital.
A copy of the Admission Document and Form of Proxy are now available on the Company's website at www.vulcantwo.com. Other than where defined, capitalised terms used in this announcement have the meanings given to them in the announcement released by the Company at 4.54 p.m. on 26 February 2026.
For further information please contact:
|
Vulcan Two Group plc Michael Kraftman, Chief Executive Officer Brendan O'Brien, Chief Operating Officer
|
Email: info@vulcantwo.com |
|
Canaccord Genuity Limited Simon Bridges / Harry Pardoe / Elizabeth Halley-Stott
|
Tel: +44 (0) 20 7523 8000 |
|
Alma Strategic Communications Justine James / Sam Modlin / Will Merison |
Email: vulcantwo@almastrategic.com Tel: +44 (0) 20 3405 0205 |